Berlin, Germany

Manne Krop

This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: B.r.a.h.m.s Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manne Krop. Retrieved from https://idiyas.com/inventor/manne-krop

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manne Krop - Innovator in Medical Diagnostics

Introduction

Manne Krop is an inventor based in Berlin, Germany. He is currently associated with B.R.A.H.M.S GmbH, where he focuses on advancements in medical diagnostics. Although he has not yet been granted any patents, his work is significant in the field of disease prognosis.

Latest Patent Applications

Manne Krop has filed several notable patent applications, including:

1. **PRO-ADRENOMEDULLIN FOR PROGNOSING DISEASE PROGRESSION IN SEVERE ACUTE RESPIRATORY SYNDROME (SARS)** - This invention relates to a method for prognosing disease progression in patients at risk of developing severe acute respiratory syndrome (SARS). The method involves determining the level of pro-adrenomedullin (proADM) in a patient sample, which indicates the severity of SARS progression.

2. **HISTONES AND/OR PROADM AS MARKERS INDICATING AN ADVERSE EVENT** - This invention focuses on the diagnosis and prognosis of adverse events, particularly mortality. It involves determining the levels of specific histones and pro-adrenomedullin in a subject's sample, which can indicate the risk of adverse events.

Conclusion

Manne Krop is making strides in the field of medical diagnostics through his innovative patent applications. His work has the potential to significantly impact the prognosis of severe diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…